RE: More on albiglutide! Good to see the confidence of GSK.
If it can be on the market by 2014, We can then expect larger orders (I would say in the $ 10-15M) in 2013 to build up the inventory in order to do the commercial launch.
$ 285M of sales could alone bring PLI break even. Some other analysts are expecting higher sales.
Time will tell, but if it's happening, PLI will definitively be in the black ink in 2013.